ICD115K ;ALB/DMR - YEARLY DRG UPDATE; October 01, 2020@15:42
;;18.0;DRG Grouper;**115**;October 20, 2000;Build 7
;Per VA Directive 6402, this routine should not be modified.
; Updates for DRGS 810-999
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
;;810^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC^1.0045^2.5
;;811^16^MED^RED BLOOD CELL DISORDERS WITH MCC^1.4036^3.8
;;812^16^MED^RED BLOOD CELL DISORDERS WITHOUT MCC^0.9007^2.8
;;813^16^MED^COAGULATION DISORDERS^1.56^3.7
;;814^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC^2.1281^4.8
;;815^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC^0.9942^3
;;816^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC^0.7102^2.3
;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC^2.255^4.3
;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC^1.1731^2.4
;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC^0.9072^1.9
;;820^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC^6.0467^11.9
;;821^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC^2.2321^3.6
;;822^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.2388^1.6
;;823^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC^4.5019^10.5
;;824^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC^2.2329^5.1
;;825^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC^1.2914^2.2
;;826^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC^4.3888^8.7
;;827^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC^2.3172^4.2
;;828^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.6404^2.5
;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC^3.1538^6.1
;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC^1.5812^2.4
;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC^1.0098^3.3
;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC^0.7377^2.5
;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC^0.5118^1.9
;;834^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC^5.599^9.9
;;835^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC^2.2355^4.6
;;836^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.1973^2.7
;;837^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC^4.7566^10.9
;;838^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT^1.9524^5.1
;;839^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.3031^4.2
;;840^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC^3.1252^6.8
;;841^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC^1.5735^4
;;842^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC^1.0664^2.7
;;843^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC^1.8606^5.4
;;844^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC^1.1572^3.7
;;845^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC^0.8649^2.7
;;846^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC^2.444^5.8
;;847^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC^1.2126^3.7
;;848^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^0.7595^2.7
;;849^17^MED^RADIOTHERAPY^2.6914^6.9
;;853^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC^4.9993^9.9
;;854^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC^2.0382^5.2
;;855^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC^1.7018^3.7
;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC^4.4284^9.4
;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC^2.1357^5.4
;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC^1.2834^3.4
;;862^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC^1.842^5.1
;;863^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC^1.0055^3.5
;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8828^2.7
;;865^18^MED^VIRAL ILLNESS WITH MCC^1.6399^4.3
;;866^18^MED^VIRAL ILLNESS WITHOUT MCC^0.9177^2.8
;;867^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC^2.0923^5.5
;;868^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC^1.0855^3.7
;;869^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC^0.6907^2.5
;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS^6.9649^13.5
;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC^1.9826^5.1
;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC^1.0299^3.6
;;876^19^SURG^O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS^3.7315^7.2
;;880^19^MED^ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION^0.9546^2.9
;;881^19^MED^DEPRESSIVE NEUROSES^0.9065^4
;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.9393^3.5
;;883^19^MED^DISORDERS OF PERSONALITY AND IMPULSE CONTROL^1.8754^5.4
;;884^19^MED^ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY^1.7569^5
;;885^19^MED^PSYCHOSES^1.3664^6.4
;;886^19^MED^BEHAVIORAL AND DEVELOPMENTAL DISORDERS^1.6817^5.4
;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.2956^3.3
;;894^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.5745^2.1
;;895^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY^1.6088^8.3
;;896^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC^1.7781^5
;;897^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC^0.8556^3.4
;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH MCC^4.3278^9.1
;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH CC^1.8847^4.6
;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC^1.2415^2.7
;;904^21^SURG^SKIN GRAFTS FOR INJURIES WITH CC/MCC^3.2562^6.9
;;905^21^SURG^SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC^1.5837^3.2
;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.8816^2.9
;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH MCC^3.7195^6.9
;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH CC^2.0041^3.8
;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC^1.3563^2.3
;;913^21^MED^TRAUMATIC INJURY WITH MCC^1.4945^3.9
;;914^21^MED^TRAUMATIC INJURY WITHOUT MCC^0.9077^2.5
;;915^21^MED^ALLERGIC REACTIONS WITH MCC^1.774^3.8
;;916^21^MED^ALLERGIC REACTIONS WITHOUT MCC^0.6588^1.8
;;917^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC^1.5959^3.9
;;918^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC^0.8609^2.5
;;919^21^MED^COMPLICATIONS OF TREATMENT WITH MCC^1.8247^4.4
;;920^21^MED^COMPLICATIONS OF TREATMENT WITH CC^1.0338^2.9
;;921^21^MED^COMPLICATIONS OF TREATMENT WITHOUT CC/MCC^0.6978^2.1
;;922^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC^1.7449^4.5
;;923^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC^1.0114^2.9
;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT^26.3587^26.4
;;928^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC^6.9197^12.6
;;929^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC^3.2155^6
;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT^3.032^2.5
;;934^22^MED^FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY^2.0925^4.9
;;935^22^MED^NON-EXTENSIVE BURNS^2.0411^3.7
;;939^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC^3.2153^6.3
;;940^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC^2.1666^3.2
;;941^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC^1.856^1.8
;;945^23^MED^REHABILITATION WITH CC/MCC^1.5095^4.8
;;946^23^MED^REHABILITATION WITHOUT CC/MCC^1.0127^3.2
;;947^23^MED^SIGNS AND SYMPTOMS WITH MCC^1.2516^3.7
;;948^23^MED^SIGNS AND SYMPTOMS WITHOUT MCC^0.801^2.6
;;949^23^MED^AFTERCARE WITH CC/MCC^1.0361^4.4
;;950^23^MED^AFTERCARE WITHOUT CC/MCC^0.6282^2.9
;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.59^1.8
;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.0902^8.3
;;956^24^SURG^LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA^3.8782^6.3
;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC^7.2325^10
;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC^4.0448^6.7
;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^2.5324^4
;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC^2.7343^5.6
;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC^1.501^3.9
;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^0.9559^2.7
;;969^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC^6.8726^13.4
;;970^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC^2.4044^5.8
;;974^25^MED^HIV WITH MAJOR RELATED CONDITION WITH MCC^2.9165^7
;;975^25^MED^HIV WITH MAJOR RELATED CONDITION WITH CC^1.3633^4.1
;;976^25^MED^HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC^0.8453^2.8
;;977^25^MED^HIV WITH OR WITHOUT OTHER RELATED CONDITION^1.4161^3.9
;;981^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^4.7404^9
;;982^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^2.486^4.3
;;983^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.6352^1.9
;;987^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^3.3767^8.2
;;988^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^1.697^4.3
;;989^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.0803^2.3
;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0^0.0
;;999^99^**^UNGROUPABLE^0.0^0.0
;;EXIT
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD115K 10690 printed Apr 09, 2024@20:54:32 Page 2
ICD115K ;ALB/DMR - YEARLY DRG UPDATE; October 01, 2020@15:42
+1 ;;18.0;DRG Grouper;**115**;October 20, 2000;Build 7
+2 ;Per VA Directive 6402, this routine should not be modified.
+3 ; Updates for DRGS 810-999
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
+1 ;;810^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC^1.0045^2.5
+2 ;;811^16^MED^RED BLOOD CELL DISORDERS WITH MCC^1.4036^3.8
+3 ;;812^16^MED^RED BLOOD CELL DISORDERS WITHOUT MCC^0.9007^2.8
+4 ;;813^16^MED^COAGULATION DISORDERS^1.56^3.7
+5 ;;814^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC^2.1281^4.8
+6 ;;815^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC^0.9942^3
+7 ;;816^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC^0.7102^2.3
+8 ;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC^2.255^4.3
+9 ;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC^1.1731^2.4
+10 ;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC^0.9072^1.9
+11 ;;820^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC^6.0467^11.9
+12 ;;821^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC^2.2321^3.6
+13 ;;822^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.2388^1.6
+14 ;;823^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC^4.5019^10.5
+15 ;;824^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC^2.2329^5.1
+16 ;;825^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC^1.2914^2.2
+17 ;;826^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC^4.3888^8.7
+18 ;;827^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC^2.3172^4.2
+19 ;;828^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.6404^2.5
+20 ;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC^3.1538^6.1
+21 ;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC^1.5812^2.4
+22 ;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC^1.0098^3.3
+23 ;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC^0.7377^2.5
+24 ;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC^0.5118^1.9
+25 ;;834^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC^5.599^9.9
+26 ;;835^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC^2.2355^4.6
+27 ;;836^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.1973^2.7
+28 ;;837^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC^4.7566^10.9
+29 ;;838^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT^1.9524^5.1
+30 ;;839^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.3031^4.2
+31 ;;840^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC^3.1252^6.8
+32 ;;841^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC^1.5735^4
+33 ;;842^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC^1.0664^2.7
+34 ;;843^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC^1.8606^5.4
+35 ;;844^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC^1.1572^3.7
+36 ;;845^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC^0.8649^2.7
+37 ;;846^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC^2.444^5.8
+38 ;;847^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC^1.2126^3.7
+39 ;;848^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^0.7595^2.7
+40 ;;849^17^MED^RADIOTHERAPY^2.6914^6.9
+41 ;;853^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC^4.9993^9.9
+42 ;;854^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC^2.0382^5.2
+43 ;;855^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC^1.7018^3.7
+44 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC^4.4284^9.4
+45 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC^2.1357^5.4
+46 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC^1.2834^3.4
+47 ;;862^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC^1.842^5.1
+48 ;;863^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC^1.0055^3.5
+49 ;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8828^2.7
+50 ;;865^18^MED^VIRAL ILLNESS WITH MCC^1.6399^4.3
+51 ;;866^18^MED^VIRAL ILLNESS WITHOUT MCC^0.9177^2.8
+52 ;;867^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC^2.0923^5.5
+53 ;;868^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC^1.0855^3.7
+54 ;;869^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC^0.6907^2.5
+55 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS^6.9649^13.5
+56 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC^1.9826^5.1
+57 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC^1.0299^3.6
+58 ;;876^19^SURG^O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS^3.7315^7.2
+59 ;;880^19^MED^ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION^0.9546^2.9
+60 ;;881^19^MED^DEPRESSIVE NEUROSES^0.9065^4
+61 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.9393^3.5
+62 ;;883^19^MED^DISORDERS OF PERSONALITY AND IMPULSE CONTROL^1.8754^5.4
+63 ;;884^19^MED^ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY^1.7569^5
+64 ;;885^19^MED^PSYCHOSES^1.3664^6.4
+65 ;;886^19^MED^BEHAVIORAL AND DEVELOPMENTAL DISORDERS^1.6817^5.4
+66 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.2956^3.3
+67 ;;894^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.5745^2.1
+68 ;;895^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY^1.6088^8.3
+69 ;;896^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC^1.7781^5
+70 ;;897^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC^0.8556^3.4
+71 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH MCC^4.3278^9.1
+72 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH CC^1.8847^4.6
+73 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC^1.2415^2.7
+74 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES WITH CC/MCC^3.2562^6.9
+75 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC^1.5837^3.2
+76 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.8816^2.9
+77 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH MCC^3.7195^6.9
+78 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH CC^2.0041^3.8
+79 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC^1.3563^2.3
+80 ;;913^21^MED^TRAUMATIC INJURY WITH MCC^1.4945^3.9
+81 ;;914^21^MED^TRAUMATIC INJURY WITHOUT MCC^0.9077^2.5
+82 ;;915^21^MED^ALLERGIC REACTIONS WITH MCC^1.774^3.8
+83 ;;916^21^MED^ALLERGIC REACTIONS WITHOUT MCC^0.6588^1.8
+84 ;;917^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC^1.5959^3.9
+85 ;;918^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC^0.8609^2.5
+86 ;;919^21^MED^COMPLICATIONS OF TREATMENT WITH MCC^1.8247^4.4
+87 ;;920^21^MED^COMPLICATIONS OF TREATMENT WITH CC^1.0338^2.9
+88 ;;921^21^MED^COMPLICATIONS OF TREATMENT WITHOUT CC/MCC^0.6978^2.1
+89 ;;922^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC^1.7449^4.5
+90 ;;923^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC^1.0114^2.9
+91 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT^26.3587^26.4
+92 ;;928^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC^6.9197^12.6
+93 ;;929^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC^3.2155^6
+94 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT^3.032^2.5
+95 ;;934^22^MED^FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY^2.0925^4.9
+96 ;;935^22^MED^NON-EXTENSIVE BURNS^2.0411^3.7
+97 ;;939^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC^3.2153^6.3
+98 ;;940^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC^2.1666^3.2
+99 ;;941^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC^1.856^1.8
+100 ;;945^23^MED^REHABILITATION WITH CC/MCC^1.5095^4.8
+101 ;;946^23^MED^REHABILITATION WITHOUT CC/MCC^1.0127^3.2
+102 ;;947^23^MED^SIGNS AND SYMPTOMS WITH MCC^1.2516^3.7
+103 ;;948^23^MED^SIGNS AND SYMPTOMS WITHOUT MCC^0.801^2.6
+104 ;;949^23^MED^AFTERCARE WITH CC/MCC^1.0361^4.4
+105 ;;950^23^MED^AFTERCARE WITHOUT CC/MCC^0.6282^2.9
+106 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.59^1.8
+107 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.0902^8.3
+108 ;;956^24^SURG^LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA^3.8782^6.3
+109 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC^7.2325^10
+110 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC^4.0448^6.7
+111 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^2.5324^4
+112 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC^2.7343^5.6
+113 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC^1.501^3.9
+114 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^0.9559^2.7
+115 ;;969^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC^6.8726^13.4
+116 ;;970^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC^2.4044^5.8
+117 ;;974^25^MED^HIV WITH MAJOR RELATED CONDITION WITH MCC^2.9165^7
+118 ;;975^25^MED^HIV WITH MAJOR RELATED CONDITION WITH CC^1.3633^4.1
+119 ;;976^25^MED^HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC^0.8453^2.8
+120 ;;977^25^MED^HIV WITH OR WITHOUT OTHER RELATED CONDITION^1.4161^3.9
+121 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^4.7404^9
+122 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^2.486^4.3
+123 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.6352^1.9
+124 ;;987^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^3.3767^8.2
+125 ;;988^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^1.697^4.3
+126 ;;989^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.0803^2.3
+127 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0^0.0
+128 ;;999^99^**^UNGROUPABLE^0.0^0.0
+129 ;;EXIT
